<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04671238</url>
  </required_header>
  <id_info>
    <org_study_id>2020PI241</org_study_id>
    <nct_id>NCT04671238</nct_id>
  </id_info>
  <brief_title>Absolute Quantification in Bone Scintigraphy</brief_title>
  <acronym>QUANTOSS-3D</acronym>
  <official_title>Absolute Quantification in Bone Scintigraphy: Phantom Evaluation and Clinical Application in Patients Undergoing Follow-up for Vertebral Fractures.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      While absolute quantification in 18F-FDG PET is widely used in clinical routine, absolute&#xD;
      quantification in SPECT (Single Photon Emission Computed Tomography) is under development and&#xD;
      its clinical interest remains to be demonstrated. Recent studies carried out on bone scan&#xD;
      recordings show the potential interest of quantification indexes such as SUV (Standard Uptake&#xD;
      Value).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In oncology, bone scan studies have reported significantly higher SUV values for secondary&#xD;
      bone lesions compared to benign osteoarticular lesions (Kuji I et al, Eur J Hybrid Imaging.&#xD;
      2017), and some have even defined an SUVmax threshold value that points to prostatic bone&#xD;
      metastases (Mohd Rohani MF, Ann Nucl Med. 2020; Tabotta F et al. BMC Musculoskelet Disord.&#xD;
      2019). A study conducted by Beck et al (EJNMMI Research 2016) evaluating the metabolism of&#xD;
      secondary bone lesions by visual analysis and SUV peak, revealed a discrepancy between visual&#xD;
      and Quantitative methods in one third of cases, thus showing the importance of these&#xD;
      quantification indexes in the analysis of these records.&#xD;
&#xD;
      In musculoskeletal pathologies, the quantification of bone scans is developing. Suh MS et al&#xD;
      (Radiology. 2016) evaluated SUVmax in bone tomoscintigraphy coupled with CT in&#xD;
      temporomandibular osteoarticular disease (Suh MS et al, Radiology. 2016). Cachovan et al&#xD;
      (EJNMMI Res. 2013) and Huang et al (Ann Nucl Med. 2020) reported a correlation between mean&#xD;
      SUV and lumbar vertebrae (LU) bone density, which reinforces the physiological significance&#xD;
      of SUVs.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2021</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To study the longitudinal follow-up in scintigraphy of patients with vertebral fractures</measure>
    <time_frame>1 year</time_frame>
    <description>Variation of the SUV over time on scans of patients with spinal fractures</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measurements of the SUV absolute quantization index</measure>
    <time_frame>1 day</time_frame>
    <description>Hounsfield numbers (UHmax, UHmean) on ghosts with known volume activities and densities</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluating absolute quantization on phantoms with objects of different volumes</measure>
    <time_frame>1 day</time_frame>
    <description>SUV absolute quantitation index (SUVmax, SUVpeak, SUVmean).</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">21</enrollment>
  <condition>Patient With Vertebroplasty</condition>
  <arm_group>
    <arm_group_label>Patient for SPECT/CT scan</arm_group_label>
    <description>Patients referred for SPECT/CT scan of the spine as part of a vertebroplasty workup and selected retrospectively.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SPECT CT</intervention_name>
    <description>SPECT/CT scan of the spine as part of a vertebroplasty</description>
    <arm_group_label>Patient for SPECT/CT scan</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients referred for SPECT/CT scan of the spine as part of a vertebroplasty workup and&#xD;
        selected retrospectively.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with recent vertebral fractures:&#xD;
&#xD;
               1. who have had at least two SPECT/CT scan scans of the spine as part of a&#xD;
                  pre-vertebroplasty check-up,&#xD;
&#xD;
               2. for which fracture dates were known.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Minor person&#xD;
&#xD;
          2. Person opposing the use of their data (Posters in waiting rooms explaining that the&#xD;
             patient must object if they do not wish their data to be used)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>BALHOUL Achraf, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHRU of Nancy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre-Yves Marie, PhD</last_name>
    <phone>+3383153475</phone>
    <email>pymarie@chru-nancy.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anne-Sophie Hue</last_name>
    <phone>+3383153475</phone>
    <email>dripromoteur@chru-nancy.fr</email>
  </overall_contact_backup>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 13, 2020</study_first_submitted>
  <study_first_submitted_qc>December 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2020</study_first_posted>
  <last_update_submitted>December 11, 2020</last_update_submitted>
  <last_update_submitted_qc>December 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>bone scintigraphy</keyword>
  <keyword>absolute quantification</keyword>
  <keyword>Standard Uptake Value</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

